Metabolic-Fit / 100
Embody review
The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Embody at a glance
- Semaglutide
- $79/mo
- Tirzepatide
- $129/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored Embody
Each factor is scored from Embody's real pricing, disclosures and oversight, then combined into the 41/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- joinem.co
Re-verified live 2026-08-04 (WLR-directory-sourced candidate, independently re-checked, not trusted from the directory copy). Homepage confirms '$79/month' semaglutide and '$129/month' tirzepatide, both flat at every dose, with a 'Summer Start Promo Applied' banner. Independent web search (2026-08-04) of Embody's Trustpilot presence found a real 3.6-3.9-star rating against marketing claims of 4.9 stars, and a recurring complaint theme of refill bills landing above the promo rate — corroborated the WLR directory's flagged caveat rather than resolving it, so the $79/$129 figures are reported as the current advertised rate with that caveat carried into cons, not as a guaranteed-forever price. No FDA warning letter found for Embody, joinem.co, or its operating entity Modern Metabolic Medicine, Inc. in the FDA's compounded-GLP1 warning-letter list (checked 2026-08-04).
What to expect when you sign up
We walked Embody's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Medical intake questionnaire covering health history, goals, and starting weight
- 2Checkout — you choose a plan and pay before the eligibility consult happens
- 3A clinician (via the OpenLoop Health network) reviews your information and decides whether a compounded GLP-1 is appropriate
- 4If approved, medication ships with free expedited delivery; you report weight every 3-4 weeks
What we noticed
- You pay at checkout BEFORE the eligibility consult — the clinician review happens after your card is charged, and Embody states a full refund only if you're disqualified or the medication is undispensed
- Async telehealth — no baseline labs or live video visit required to start
- Four named pharmacies (RedRock, Health Warehouse, Precision Compounding, Triad Rx) — more dispensing transparency than most compounded platforms disclose
- A 6-month satisfaction guarantee is advertised, but read the exact terms before relying on it
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 | Injection (flat at every dose)Live-checked 2026-08-04: homepage states '$79/month' with a 'Summer Start Promo Applied — Save $200 instantly' banner and an FAQ line that 'your price remains the same each month as long as you're on the same medication and treatment plan.' No separate list price is shown on the current site, but Embody's own terms have previously stated a $199/mo list price behind the promo, and Trustpilot complaints describe refill bills above the rate customers signed up at — treat the $79 as the current advertised rate, not a guaranteed-forever number. |
| Compounded tirzepatide | $129 | Injection (flat at every dose)Homepage states '$129/month'; the checkout tile has separately advertised a $119/mo flat rate — confirm the exact figure at checkout. |
| Oral semaglutide | $229 | OralNew oral semaglutide option; no injection required. |
| Oral tirzepatide | $329 | Oral / gumA compounded oral tirzepatide gum — an unusual delivery format uncommon among telehealth GLP-1 platforms. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Embody's public disclosures at last review and change often; confirm the current number on Embody's own site.
What we like
- Among the lowest flat rates we checked this pass — $79/mo semaglutide, $129/mo tirzepatide at every dose
- A genuinely unusual compounded oral tirzepatide gum option for mothers who'd rather not inject
- Four named pharmacy partners — more dispensing transparency than most compounded platforms disclose
- 24/7 clinician messaging and a 6-month satisfaction guarantee are both real, stated benefits
The caveats
- You pay at checkout before the eligibility consult happens — refund is only guaranteed if you're disqualified or the medication is undispensed
- The $79/mo rate depends on a promo Embody says is 'locked forever,' but the company's own terms have separately listed a $199/mo list price, and Trustpilot complaints describe refill bills landing higher than advertised
- Compounded only — no FDA-approved brand-name Wegovy, Ozempic, Zepbound, or Mounjaro option
- Nothing on the site addresses pregnancy or breastfeeding specifically
Embody for mothers: our verdict
The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens. It runs about $79/month, flat across every dose — toward the affordable end of what we track.
We weigh Embody the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Embody actually costs
- Compounded semaglutide — Injection (flat at every dose): $79/mo
- Compounded tirzepatide — Injection (flat at every dose): $129/mo
- Oral semaglutide — Oral: $229/mo
- Oral tirzepatide — Oral / gum: $329/mo
That sits below the roughly $168 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Embody prescribes
Embody prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Embody fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around postpartum and breastfeeding timing, not an auto-approving quiz.
- the monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Embody is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother comfortable paying at checkout before the eligibility review, chasing the lowest advertised sticker price, who will get the renewal terms confirmed in writing rather than trusting the 'locked forever' promo language alone.
Alternatives to Embody
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Embody
Head-to-head & alternatives
Embody, answered
- Is Embody's $79/mo price guaranteed to stay that low?
- It's the current advertised rate, tied to a 'Summer Start' promo Embody says is locked in for as long as you stay on the same plan. But the company's own terms have separately listed a $199/mo list price, and real Trustpilot reviews describe refill bills coming in above the rate customers signed up at. Get the exact renewal price in writing before you rely on $79 being permanent.
- Does Embody address breastfeeding or pregnancy?
- No — we found nothing on Embody's site addressing pregnancy, breastfeeding, or postpartum timing specifically. No GLP-1, compounded or brand, is established as safe in either, so that's a conversation to have with your own OB regardless of what a provider's marketing does or doesn't say.
- Why does Embody make you pay before the consult?
- Embody charges your card at checkout, and the clinician eligibility review happens afterward — the reverse of a 'consult first' model. Embody says you get a full refund if you're disqualified or the medication is never dispensed, but you're extending trust on the billing sequence before a clinician has looked at your history.
- What is the oral tirzepatide gum, and is it FDA-approved?
- It's a compounded oral tirzepatide formulation in gum form — an unusual delivery method most telehealth GLP-1 platforms don't offer. It is not FDA-approved, and oral GLP-1 bioavailability is still an active area of clinical debate, so treat it as a novel option to discuss with a clinician rather than an established alternative to the injection.
Pricing, states and verification reflect Embody's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.